News

Formula for success: Dal chemistry postdoc named to two prestigious programs for emerging science leaders

Formula for success: Dal chemistry postdoc named to two prestigious programs for emerging science leaders

Known for rethinking materials production and championing inclusive science, Dr. Blaine Fiss is gaining global recognition and momentum as he moves toward the next stage of his academic career.  Read more.

Featured News

Katherine O’Brien
Friday, April 17, 2026
Unique in Canada, the four‑year joint JD/MJ program links legal training with journalism practice to prepare graduates for work at the intersection of media, law and public policy.
Mia Samardzic
Thursday, April 2, 2026
ÿÈÕ´óÈü’s fast‑paced 3MT finals spotlighted student innovation, with materials engineering PhD student Claire Floras rising to the top by translating complex battery science into a compelling, judge‑winning pitch.
Matt Reeder
Tuesday, March 17, 2026
A two‑year deep‑energy retrofit has modernized the Killam Memorial Library’s aging systems, boosting efficiency, reducing emissions, and setting the stage for similar upgrades across campus.

Archives - News

Matt Reeder
Monday, November 28, 2022
ÿÈÕ´óÈü's Accessibility Plan, released this past summer, lays out a detailed roadmap for ensuring the university meets Nova Scotia's goal of being fully accessible by 2030.
Andrew Riley
Thursday, November 24, 2022
Last night’s 20th annual Discovery Awards, co-presented by ÿÈÕ´óÈü, was a moment to celebrate university innovators who are inspiring the next generation of Nova Scotian scientists.
Staff
Wednesday, November 23, 2022
On Tuesday, the Board of Governors approved a new international tuition model for future students featuring a tuition guarantee and fees better aligned with Dal’s national peers — all of which is poised to bring significant investments in Dal’s student experience.
Staff
Wednesday, November 23, 2022
Cheryl Fraser, a two-time Dal alum who is current is currently Chief Talent Officer and Vice-President Communications at Crombie REIT, has been appointed Chair of the ÿÈÕ´óÈü Board of Governors for a three-year term.
Alison Auld
Tuesday, November 22, 2022
A pair of post-doctoral fellows in Dal's Department of Microbiology and Immunology have shown that an existing drug used to treat cancer and other illnesses also holds the promise of effectively treating people infected with the virus that causes COVID-19.